Veeva Systems announced that Daiichi Sankyo, one of the world’s top 20 pharmaceutical companies, is replacing its legacy, on-premise Customer Relationship Management (CRM) system with Veeva CRM in the UK. Daiichi Sankyo will deploy Veeva CRM to all of its commercial teams in the UK including integrated healthcare, specialty care, medical liaison scientists, and head-office teams (i.e., marketing and medical) to drive more effective customer engagement.
Daiichi Sankyo had outgrown its current CRM system, according to executives. “Most of our customer-facing teams were only using the system as a basic customer information repository,” said Dr. Simon Clough, managing director for Daiichi Sankyo UK. “It lacked important functionality and so became nothing more than an expensive database to record calls. We were looking for a system that offered functionality well beyond just call recording.”
After researching alternative CRM systems, Daiichi Sankyo decided on Veeva CRM. “We’re all about innovation that leads to enhanced quality and value for our customers,” said Clough. “We’ve adopted an innovative agenda for advancing everything from our science to our interactions with stakeholders, and Veeva CRM supports it perfectly. The system’s intuitive, easy-to-use interface and rich functionality are part of our strategy for strengthening customer engagements in the UK’s changing NHS environment.”
Daiichi Sankyo was also drawn to Veeva iRep, which is the first integrated Pharma CRM and CLM solution designed for the Apple iPad. Clough continued, “We recognised that the system’s closed-loop marketing functions and the device’s beautiful presentation of multi-media content would support more interactive customer engagements. With iRep, we expect that our account specialists will be more connected, responsive, and effective.”
Veeva Systems has rapidly become the leading provider of Pharma CRM solutions globally. Cloud-based, Veeva CRM requires no hardware or software to purchase, scale or maintain. In addition, all Veeva customers benefit from free, automatic upgrades so users are always on the most up-to-date version of the software and benefit from the very latest compliance changes and system enhancements. Changes can be made to the system instantly without user retraining or additional third-party costs.
Bill Barone, head of learning & innovation at Daiichi Sankyo UK concluded, “We are very excited to work with a pioneering CRM organisation. Veeva is ahead of the curve and leading the market from an innovation perspective.”
The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets.
The Veeva CRM suite of applications, comprised of VBioPharma, iRep, VMobile, and VInsights, is the pharmaceutical and biotechnology industry’s leading cloud-based CRM solution. In addition, iRep has quickly become the industry’s choice for closed loop marketing on the iPad.
Veeva Systems is the leader in cloud-based solutions for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has over 90 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs.